Status:
RECRUITING
LevineConservationModelandColorectalPatients
Lead Sponsor:
KTO Karatay University
Collaborating Sponsors:
Necmettin Erbakan University
Conditions:
Fatigue
Peripheral Neuropathy
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Colorectal cancer is one of the most common types of cancer in the world, ranking 3rd among cancers that cause death in men and women. In patients diagnosed with colorectal cancer, chemotherapy treatm...
Eligibility Criteria
Inclusion
- Between the ages of 18-75
- Diagnosed with primary and new colorectal cancer (Stage II and III),
- The decision to start the FOLFOX treatment protocol has been taken,
- Having a smartphone,
- Being literate,
- Ability to speak and understand Turkish,
- Open to communication and cooperation.
Exclusion
- History of neuropathy or diabetes,
- History of hypothyroidism, renal failure,
- Hearing, speech and vision problems,
- Receiving radiotherapy or immunotherapy,
- Psychiatric diagnosis or ongoing treatment.
Key Trial Info
Start Date :
March 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06499129
Start Date
March 20 2025
End Date
December 30 2026
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Necmettin Erbakan University
Konya, Meram, Turkey (Türkiye)